Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1993Antimicrobial Agents and Chemotherapy

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSarah H. CheesemanLeeds Teaching Hospitals NHS TrustSHSusan E. HattoxBoehringer Ingelheim (United States)MMMargaret McLaughlinMassachusetts General Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cheeseman et al. (1993) studied this question.

synapsesocial.com/papers/6a90f3bdf69e67dea43611d0https://doi.org/10.1128/aac.37.2.178
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor1990 · 745 citations
  2. 2Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.1991 · 394 citations
  3. 3Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.1991 · 104 citations
  4. 4Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors1991 · 363 citations
  5. 5BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine1991 · 157 citations